~~<i id='7B57386E05'><strike id='7B57386E05'><tt id='7B57386E05'><pre id='7B57386E05'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：knowledge 2025-09-30 18:55:23 - browse：38847

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Sickle cell gene therapy cures need to be accessible in Africa

Wikipedia

focus

hotspot

entertainment

1:44AmanwalksdownastreetfloodedbyrecentrainstormsinMontpelier,Vermont,onJuly11,2023.BrianSnyder/Reut

WSS

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Sickle cell gene therapy cures need to be accessible in Africa

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

The debate over Covid

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

hotspot

explore

Wikipedia

ChatGPT in medicine: STAT answers readers' burning questions

States should stop sabotaging methadone treatment reform

Sports medicine is finally prioritizing gender equality

Oprah kicked off a national conversation on obesity. Let's have it

Medical records are filled with copy

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Hollywood unions extend contract negotiations for actors

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

23andMe had bad news about my health. I wish a person had delivered it

Grail's uphill battle for Medicare to cover its cancer screening test

focus

Oprah kicked off a national conversation on obesity. Let's have it

Abortion pill Supreme Court ruling could impact entire drug industry

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Superbugs, antibiotic resistance get scrutiny in congress

FDA's naming rule on biosimilars has undermined competition

Scientists boost immune system in aging mice by making it youthful

focus

focus

hotspot

entertainment